In one study, the company’s drug eased the agitation for Alzheimer’s patients. In a different study, there wasn’t a ...
Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...
The legislative rush provided another example of state lawmakers struggling to reach consensus on significant policy matters, ...
Drug overdose deaths fell sharply in San Francisco in 2024. Experts credit better access to overdose-reversal medication and ...
Adults with ADHD are more at risk for road accidents, motor vehicle injuries, traffic tickets, and hard braking events.
UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung ...
Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
Veeda Group has rebranded to Veeda Lifesciences, reflecting its evolution into a drug development enterprise. It comprises four strategic units: Clinical Trials, Healthy Volunteer Services, Biopharma ...
Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...
(CNN) — Medicare beneficiaries who take a lot of pricey medications will get a big break in 2025. That’s when the $2,000 ...